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Abstract 
Objective: Steroid hormones are responsible for the control of a wide range of physiological processes such as 
development, growth, reproduction, metabolism, and aging. Because of the variety of enzymes, substrates and 
products that take part in steroidogenesis and the compartmentalisation of its constituent reactions, it is a complex 
process to visualise and document. One of the goals of systems biology is to quantitatively describe the behaviour of 
complex biological systems that involve the interaction of many components. This can be done by representing these 
interactions visually in a pathway model and then optionally constructing a mathematical model of the interactions.
Results: We have used the modified Edinburgh Pathway Notation to construct a framework diagram describing 
human steroidogenic pathways, which will be of use to endocrinologists. To demonstrate further utility, we show how 
such models can be parameterised with empirical data within the software Graphia Professional, to recapitulate spe-
cific examples of steroid hormone production, and also to mimic gene knockout. These framework models support in 
silico hypothesis generation and testing with utility across endocrine endpoints, with significant potential to reduce 
costs, time and animal numbers, whilst informing the design of planned studies.
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Introduction
Steroid hormones are responsible for the control of a 
wide range of physiological processes such as develop-
ment, growth, reproduction, metabolism, and aging. 
Mammalian steroidogenesis uses cholesterol as a start-
ing substrate to produce the steroid hormone classes of 
androgens, estrogens, progestogens, corticosteroids and 
mineralocorticoids. The initial conversion of cholesterol 
to the major biologically active steroids takes place pri-
marily in the gonads, adrenals and placenta, but further 
specific interconversions can take place in peripheral tis-
sues due to local expression of other enzymes (reviewed 
in [1]).
Because of the variety and location of the components 
that take part in steroidogenesis it is a complex process 
to visualise and document. However, over the years many 
attempts have been made, and searching for ‘steroido-
genesis’ in Google images provides examples of these 
results. Some diagrams are incomplete and focus only on 
the steroid products without representing the enzymes 
that produce them; others focus only on the products of 
one particular organ. Steroidogenic enzymes often have 
more than one name or symbol (for example the enzyme 
cytochrome p450 side-chain cleavage is often referred to 
as p450scc in older literature, but has the gene symbol 
CYP11A1 in humans). Many steroidogenesis diagrams 
often use non-standard nomenclature, or interchange 
gene names across species when the gene is specific to 
one species. Almost all pathway diagrams of steroidogen-
esis have no way of incorporating references into the dia-
gram reducing their value as a learning resource for the 
end user.
One of the goals of systems biology is to quantitatively 
describe the behaviour of complex biological systems 
that involve the interaction of many components. This 
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can be done by representing these interactions visually 
in a pathway model and then optionally constructing a 
mathematical model of the interactions. Steroidogenesis 
would greatly benefit from a formalised graphical docu-
mentation using a standard notation with links to origi-
nal research articles and chemical structures of steroid 
intermediates. If the diagram could be parameterised to 
form a dynamic mathematical model it could potentially 
be used to predict what steroid pathways would be active 
and what products could be made by tissues expressing a 
particular combination of steroidogenic enzymes.
In this paper, we have used the modified Edinburgh 
pathway notation (mEPN) to construct a framework dia-
gram describing human steroidogenic pathways, which 
will be of use to endocrinologists. To demonstrate further 
utility, we show how such models can be parameterised 
with empirical data within the software Graphia Profes-
sional [2], to recapitulate specific examples of steroid 
hormone production, and also to mimic gene knockout. 
These framework models support in silico hypothesis 
generation and testing with utility across endocrine end-
points, with significant potential to reduce costs, time 
and animal numbers, whilst informing the design of 
planned studies.
Main text
Construction of pathway models of steroidogenesis using 
the mEPN notation
A model of human steroidogenesis is presented in Fig. 1, 
representing a framework of the reactions that produce 
biologically active steroids under normal conditions. 
Diagrams were compiled using the modified Edinburgh 
pathway notation (mEPN) using the network editing soft-
ware yED (http://www.ywork s.com). The editable version 
of this diagram is available as a ‘.graphml’ file that can be 
opened in yED (Additional file  1). Steroid and enzyme 
interaction information was obtained from Miller et  al. 
[1] and associated references. Active pathways in differ-
ent tissues (namely the adrenal reticularis, glomerulosa 
and fasciculata, the testis, ovary, prostate and placenta, 
Additional file 2) are highlighted with red boxes to eas-
ily visualise the steroidogenic reactions that take place in 
each tissue.
mEPN is based on the principles of ‘process diagrams’ 
and is designed to be unambiguous yet concise [3]. A 
detailed protocol of how to edit mEPN diagrams has 
been recently published [4]. Both the biological entities 
(such as proteins or steroids) and the way they interact 
with each other (such as phosphorylation or dimerisa-
tion) are represented as components in the pathway. 
Small biochemicals such as steroids are represented by 
hexagons, all proteins (enzymes) by rounded rectangles 
and all genes by parallelograms. Black rectangles allow 
for parameterisation of models whereby initial token 
input on nodes feeding into the pathway can be defined 
(Fig. 1b). It can be expanded to produce large, clear and 
informative pathway models [5, 6].
We have chosen to label steroids and their intermedi-
ates based on names in common use in the biological 
community but have also linked nodes to the Chemspi-
der database (http://www.chems pider .com). This pro-
vides a reference to the exact biochemical structure a 
molecule represents and gives alternate names. The link 
can be opened by pressing the F8 key when the node is 
highlighted in yED (Fig. 1c). There are number of nam-
ing conventions for biochemical molecules. The com-
prehensive diagram of the major steroidogenic pathways 
(Fig.  1a) contains nodes to represent both the gene and 
the protein produced for each enzyme isoform, and 
therefore each gene node is linked to Ensembl (http://
www.ensem bl.org) [7].
Construction and parameterisation for dynamic flow 
of a cell‑specific model of rat Leydig cell steroidogenesis 
using previously‑published experimental data
Whilst the formalised framework diagram has utility as a 
resource in its own right, the ability to parameterise the 
pathway and run and test simulations immeasurably adds 
to its overall value. We constructed and parametrised a 
specific model of rat Leydig cell steroidogenesis during 
postnatal development and adulthood (Fig.  2) focussing 
on the specific reactions that Leydig cells use to produce 
their main steroid product: androgens. The simplified 
Leydig cell version (Fig. 2a) uses a single protein node to 
represent all isoforms of a particular enzyme and so an 
Ensembl link is not included. The editable version of the 
simplified diagram is also available as a ‘.graphml’ file that 
can be opened in yED, (Additional file 3).
Parameterisation of pathway diagrams constructed in 
yED to run as a signalling Petri nets (SPNs) in the soft-
ware Graphia Professional is a logical process and no for-
mal training in mathematical modelling is necessary for 
the user. A detailed description of how to parameterise 
yED diagrams so that they can be run as SPNs in Graphia 
Professional (Kajeka, Edinburgh, UK, formerly BioLay-
out Express3D) [2] can be found in Livigni et  al. [4]. By 
representing a complex network as a Petri net, the SPN 
method models signal flow as the pattern of token accu-
mulation at protein nodes over time.
Parameterisation of the cell-specific diagram was 
achieved using previously published enzyme activity data 
measured at three different stages of rat Leydig cell matu-
ration [8]. In yED, tokens representing the enzyme activ-
ity in pmol/minute/million cells were added to the arrows 
connecting the black input nodes of each of the steroido-
genic enzyme nodes using the notation a–b,c;d–e,f where 
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‘a–b’ are the first and last time blocks that you would like 
the number of tokens ‘c’ to be added to the model and 
‘d–e’ are the first and last time blocks that you would like 
the number of tokens ‘f ’ to be added to the model (and 
so on for the number of variable inputs required), as 
shown in Fig. 2a. The first 20 time blocks represent the 
‘progenitor’ Leydig cell stage present at around postna-
tal day (pnd) 21 in the rat. Time blocks 21–50 represent 
the ‘immature’ Leydig cell stage present at around pnd 35 
and time blocks 51–100 represent the mature adult Ley-
dig cell that constitute all of the Leydig cells in the testis 
from pnd 90 onwards. The variation in enzyme activity at 
the three stages is illustrated by the black bar graphs next 
to the enzyme input nodes in Fig. 2a. The editable version 
of the parameterised diagram is available as a ‘.graphml’ 
file that can be opened in yED (Additional file 4).
Fig. 1 Construction of a framework model of human steroidogenesis. a An image of the editable framework model of human steroidogenesis. b A 
key to the symbols used in the diagram. c Addition of a Chemspider URL to a steroid node by editing the properties of the node in yED
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The parameterised diagram was run as a SPN in 
Graphia Professional over 100 time blocks, 500 runs 
and with standard normal stochastic distribution and 
consumptive transitions [2]. The token flow was visual-
ised as an animation seen in Additional file 5. Figure 2b 
shows a screenshot of the animated output of the token 
flow at each of the three stages (screenshots taken at 
time block 20 representing progenitor, 50 representing 
immature and 100 representing adult Leydig cell stages). 
This provides an overview of all of the nodes in the dia-
gram and helps visualise the pathways of token flow. Two 
nodes were selected for specific visualisation in Fig.  2c: 
Fig. 2 Construction, paramaterisation and hypothesis testing using a cell-specific model of rat Leydig cell steroidogenesis. a An image of the 
editable framework of rat Leydig cell steroidogenesis, with parameterisation details. The black bar graphs next to each enzyme input show the 
number of tokens added to each enzyme node at the three stages of progenitor, immature and adult Leydig cell. The tokens are introduced to 
the node by editing the properties of the arrow leading from the token input to the node, and are visible as a numerical string next to the node. 
Androstenedione is indicated by a green ring, testosterone in blue and 3α-diol in red. b Still frames from the dynamic signalling Petri net outputs of 
the Leydig cell model at the three stages of progenitor, immature and adult. Each of the coloured shapes on the diagram represents a steroid node 
in the same position as the yED diagram above. Larger red shapes indicate more tokens are flowing through that node, smaller blue shapes indicate 
fewer and no shape indicates no tokens. c A graph visualising the flow of tokens through the nodes representing testosterone (blue) and 3α-diol 
(red) over the course of Leydig cell maturation. The coloured areas around the line indicate the variance of the output
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testosterone and 3α-androstanediol (‘3α-diol’). If these 
outputs are taken as a prediction of the relative produc-
tion rate of these two steroids at immature and adult 
Leydig cell stages, we would predict that 3α-diol is more 
abundant than testosterone in immature Leydig cells and 
that testosterone is more abundant than 3α-diol in adult 
Leydig cells. This prediction of the model is consistent 
with previous experimental measurement [8], showing 
that our model appropriately recapitulates the in vivo sit-
uation and thus has utility for hypothesis testing.
Using the model to predict steroid production in Hsd17b3 
deficiency
Enzymes of the 17-beta hydroxysteroid dehydroge-
nase class catalyse the conversion between 17-keto and 
17-hydroxy-steroids. Different isoforms of the enzyme 
are expressed in different steroidogenic tissues. 17-beta 
hydroxysteroid dehydrogenase type 3 is the isoform 
expressed by Leydig cells in humans (HSD17B3), mice 
and rats (Hsd17b3) [9] and preferentially catalyses the 
conversion of androstenedione to testosterone and 
androstanedione to DHT. Male humans with mutations 
in HSD17B3 present with varying degrees of physiologi-
cal undervirilisation and plasma androstenedione lev-
els at the time of puberty are usually ten times normal 
levels [10]. To demonstrate the predictive power of our 
in silico model, we mimicked a loss of function muta-
tion in Hsd17b3 by removing the token input from the 
HSD17B node of the rat Leydig cell model (Fig.  3a, b), 
and re-ran the simulation. This time tokens accumulated 
Fig. 3 Using the model to predict the outcome of a HSD17B knockout in Leydig cells. a The labelling of the HSD17B protein activity node in a 
wild-type model. b The removal of the arrow between the token input and the protein node sets token input to zero and models a knockout of 
the protein. c A still frame from the dynamic signalling Petri net outputs of the HSD17B knockout Leydig cell model at the adult stage. Each of the 
coloured shapes on the diagram represents a steroid node in the same position as the yED diagram above. Larger red shapes indicate more tokens 
are flowing through that node, smaller blue shapes indicate fewer and no shape indicates no tokens. d A graph visualising the flow of tokens 
through the nodes representing testosterone (blue) and androstenediol (green) over the course of Leydig cell maturation. The coloured areas 
around the line indicate the variance of the output
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at the androstenedione node, with no testosterone pro-
duced, consistent with the circulating androgen profile 
observed in patients with a loss of function of HSD17B3 
(Fig. 3c). When visualised as a graph (Fig. 3d), androsten-
edione production is shown to increase as Leydig cells 
mature during postnatal life, whereas no testosterone is 
produced. This simple demonstration shows the utility of 
the model for predicting outcomes of genetic or pharma-
cological manipulations before beginning any laboratory 
or in vivo work, and has the potential to be scaled with 
multiple knockouts modelled simultaneously.
Limitations
The system we describe here presents many significant 
advantages over previous modelling systems. The soft-
ware is free and readily available, and is supported by two 
recent publications explaining the underlying methodol-
ogy [2], and specific protocols that describe the editing 
of existing models and construction of new models. In its 
graphical form within yED, specific nodes within a dia-
gram can be hyperlinked to publications describing the 
supporting evidence and to references to correct gene 
and chemical nomenclature. As such the diagram can 
represent a visual bibliography of known interactions and 
supporting data, and we have found this to be a much-
appreciated resource by anyone grappling to conceptual-
ise the complexities of the endocrine system.
The true power of the framework diagram is revealed 
when combined with stochastic modelling within 
Graphia Professional. Traditionally, systems dynamics are 
described using continuous deterministic mathematical 
models, which assume that the system has no unpredict-
ability and that the precise behaviour of its components 
is entirely pre-determined. However, biological systems 
are intrinsically stochastic and there is evidence that sto-
chasticity is advantageous [11]. In this case, Petri nets, 
which are a mathematical modelling language for the 
description of distributed systems, allow for the study of 
dynamics without the need to have detailed information 
on the kinetics. It also means that the system is signifi-
cantly more ‘biologist friendly’ than mathematical mod-
elling through ordinary differential equations.
The system can be used where information is missing, 
as it is possible to substitute a single arrow (edge) to rep-
resent an uncharacterised event between two established 
known molecules, which permits modelling to continue 
without possession of all information. Thus, some areas 
of the model may be incredibly detailed, whilst others are 
described in less detail. This may identify areas and com-
ponents that are missing, but must be necessary, thereby 
focussing hypothesis generation and laboratory experi-
ments in these key locations to refine understanding.
In conclusion, the development of this framework 
model of steroidogenesis using free software to edit and 
construct new models will support in silico hypoth-
esis generation and testing across many endocrine end-
points. Use of this system has significant potential to 
reduce costs, time and animal numbers, whilst inform-
ing the design of planned studies.
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